RAC 1.11% $1.83 race oncology ltd

The asx announcement for preclinical melanoma studies indicates...

  1. 53 Posts.
    lightbulb Created with Sketch. 42
    The asx announcement for preclinical melanoma studies indicates that they will be testing zantrene with PDL1.
    I would have believe that they will test against all PDL1 in that preclinical work, otherwise the best combination therapy might not be discovered.
    Hope that helps.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.